Global Ibuprofen API Market Growth 2025-2031

The global Ibuprofen API market size is predicted to grow from US$ 771 million in 2025 to US$ 1063 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Ibuprofen (API), also known as ibuprofen, is a non-steroidal anti-inflammatory drug for antipyretics and analgesia. It has good anti-inflammatory, analgesic and antipyretic effects. Compared with general anti-inflammatory and analgesic drugs, it has strong effects and few side effects. It has no obvious side effects on the liver, kidneys and hematopoietic system, especially the gastrointestinal tract. At present, ibuprofen has been included in the pharmacopoeias of many countries such as China, the United States, the United Kingdom, Japan, and the European Pharmacopoeia. It has been widely used around the world and has become one of the world's best-selling over-the-counter drugs.

The Ibuprofen API (Active Pharmaceutical Ingredient) market is primarily driven by the increasing global demand for pain relief and anti-inflammatory medications. Ibuprofen is one of the most commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) for treating conditions such as arthritis, fever, headaches, menstrual pain, and other types of mild to moderate pain. The rising prevalence of chronic conditions, such as osteoarthritis and other inflammatory diseases, is driving the demand for Ibuprofen APIs. Additionally, the growing aging population and increasing awareness about over-the-counter (OTC) pain relief medications have contributed to the market's expansion. Manufacturers are also benefiting from the widespread availability of generic Ibuprofen formulations, which have made the drug more accessible and affordable.

However, the market faces challenges related to regulatory scrutiny and competition in the generic drug market. The production of Ibuprofen APIs requires strict compliance with regulatory standards, and companies must invest in quality control to ensure the safety and efficacy of the product. Furthermore, the generic nature of Ibuprofen leads to intense price competition among manufacturers, squeezing profit margins and making it difficult for companies to maintain market share. Another challenge is the rising concern about the side effects of prolonged Ibuprofen use, such as gastrointestinal issues and cardiovascular risks, which may impact consumer confidence and demand in the long term.

Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.

LP Information, Inc. (LPI) ' newest research report, the “Ibuprofen API Industry Forecast” looks at past sales and reviews total world Ibuprofen API sales in 2024, providing a comprehensive analysis by region and market sector of projected Ibuprofen API sales for 2025 through 2031. With Ibuprofen API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ibuprofen API industry.

This Insight Report provides a comprehensive analysis of the global Ibuprofen API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ibuprofen API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ibuprofen API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ibuprofen API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ibuprofen API.

This report presents a comprehensive overview, market shares, and growth opportunities of Ibuprofen API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
USP
EP

Segmentation by Application:
Contract Manufacturing Organizations
Pharmaceutical Companies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
IOLCP
SOLARA
Shandong Xinhua Pharmaceutical
Biocause
BASF
SI Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ibuprofen API market?

What factors are driving Ibuprofen API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ibuprofen API market opportunities vary by end market size?

How does Ibuprofen API break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.